Authors: Havlik, E Pirich, C Preitfellner, J Karanikas, G Schaffarich, P Hefner, A Sinzinger, H

Citation: E. Havlik et al., Radiation exposure from patients treated with Dy-165-ferric hydroxide, NUCL MED C, 22(1), 2001, pp. 79-82

Authors: Virgolini, I Traub, T Leimer, M Novotny, C Pangerl, T Ofluoglu, S Halvadjieva, E Smith-Jones, P Flores, J Li, SR Angelberger, P Havlik, E Andreae, F Raderer, M Kurtaran, A Niederle, B Dubczak, R

Citation: I. Virgolini et al., New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy, Q J NUCL M, 44(1), 2000, pp. 50-58

Authors: Pirich, C Pilger, A Schwameis, E Germadnik, D Prufert, U Havlik, E Lang, S Kvaternik, H Flores, JA Angelberger, P Wanivenhaus, A Rudiger, HW Sinzinger, H

Citation: C. Pirich et al., Radiation synovectomy using Dy-165 ferric-hydroxide and oxidative DNA damage in patients with different types of arthritis, J NUCL MED, 41(2), 2000, pp. 250-256

Authors: Zettinig, G Karanikas, G Hanselmayer, G Havlik, E Dudczak, R

Citation: G. Zettinig et al., Radioactive contamination of contact lenses during radioiodine therapy, NUCL MED C, 21(10), 2000, pp. 955-957

Authors: Virgolini, I Kurtaran, A Angelberger, P Raderer, M Havlik, E Smith-Jones, P

Citation: I. Virgolini et al., "MAURITIUS": Tumour dose in patients with advanced carcinoma, ITAL J GAST, 31, 1999, pp. S227-S230

Authors: Leimer, M Kurtaran, A Smith-Jones, P Raderer, M Havlik, E Angelberger, P Vorbeck, F Niederle, B Herold, C Virgolini, I

Citation: M. Leimer et al., Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma, J NUCL MED, 39(12), 1998, pp. 2090-2094